Creative Planning Verve Therapeutics, Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 15,837 shares of VERV stock, worth $176,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,837
Previous 20,296
21.97%
Holding current value
$176,265
Previous $92,000
92.39%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VERV
# of Institutions
201Shares Held
85.1MCall Options Held
350KPut Options Held
186K-
Alphabet Inc. Mountain View, CA12.2MShares$135 Million8.86% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$76.8 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.19MShares$46.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.5 Million2.14% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...